Uveal melanoma (UM) is the most common primary intraocular tumor. Despite successful treatment of the primary tumor, 50% of patients develop distant metastases. To date, there are no clear standards for choosing the first line of therapy for metastatic UM. The article presents a retrospective analysis of the effectiveness and safety of first-line therapy in 125 patients with metastatic UM who applied to the N.N. Blokhin National Medical Research Center of Oncology in the period from 2020 to 2023.
No takes yet. Share an insight, caveat, or question.
Nazarova et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: